Myriad Genetics, Inc. (MYGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157839,
    "name": "Myriad Genetics, Inc.",
    "stock_name": "Myriad Genetics, Inc.",
    "full_name": "Myriad Genetics, Inc.",
    "name_url": "stocks-analysis/myriad-genetics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.33",
    "chg": 0.31,
    "chgp": "4.42%",
    "dir": 1,
    "prev_price": "7.02",
    "mcapval": "642.94",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US62855J1043",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "445.76 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/myriad-genetics-inc-1157839-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Myriad Genetics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-myriad-genetics-inc-technically-bullish-or-bearish-3545484",
        "imagepath": "",
        "date": "2025-09-20 19:12:42",
        "description": "As of 8 September 2025, the technical trend for Myriad Genetics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals across time frames. The daily moving averages are mildly bearish, while the Bollinger Bands show a bullish stance weekly but mildly bearish monthly. The KST is bullish weekly but bearish monthly, and the Dow Theory indicates no trend weekly and mildly bullish monthly. Overall, the technical stance is mildly bearish due to the predominance of bearish indicators, particularly in the moving averages and monthly metrics. \n\nIn terms of performance, the stock has significantly underperformed the S&P 500 over the past year, down 73.02% compared to the S&P's 17.14% gain, and has also lagged over longer periods, including a 5-year decline of 40.6% against the S&P's 96.61% increase...."
      },
      {
        "title": "Is Myriad Genetics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-myriad-genetics-inc-overvalued-or-undervalued-3542187",
        "imagepath": "",
        "date": "2025-09-20 17:46:53",
        "description": "As of 4 November 2019, the valuation grade for Myriad Genetics, Inc. moved from expensive to risky, indicating a shift in perception regarding its financial health. Given the current metrics, the company appears to be overvalued, particularly with a Price to Book Value of 0.67 and an EV to Sales ratio of 0.54, which suggest that the market is not pricing in sufficient value relative to its assets and sales. Additionally, the negative EV to EBITDA of -15.22 further underscores the challenges the company faces in generating earnings.\n\nIn comparison to its peers, Myriad Genetics, Inc. has a significantly lower EV to EBITDA ratio than Owens & Minor, Inc. at 4.7461 and Pacific Biosciences of California, Inc. at -4.2891, indicating that it is struggling more than its competitors in terms of operational efficiency. Furthermore, the company's stock has underperformed relative to the S&P 500, with a year-to-date ret..."
      }
    ],
    "total": 7,
    "sid": "1157839",
    "stock_news_url": "https://www.marketsmojo.com/news/myriad-genetics-inc-1157839"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Myriad Genetics, Inc. technically bullish or bearish?

2025-09-20 19:12:42

As of 8 September 2025, the technical trend for Myriad Genetics, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals across time frames. The daily moving averages are mildly bearish, while the Bollinger Bands show a bullish stance weekly but mildly bearish monthly. The KST is bullish weekly but bearish monthly, and the Dow Theory indicates no trend weekly and mildly bullish monthly. Overall, the technical stance is mildly bearish due to the predominance of bearish indicators, particularly in the moving averages and monthly metrics. In terms of performance, the stock has significantly underperformed the S&P 500 over the past year, down 73.02% compared to the S&P's 17.14% gain, and has also lagged over longer periods, including a 5-year decline of 40.6% against the S&P's 96.61% increase....

Is Myriad Genetics, Inc. overvalued or undervalued?

2025-09-20 17:46:53

As of 4 November 2019, the valuation grade for Myriad Genetics, Inc. moved from expensive to risky, indicating a shift in perception regarding its financial health. Given the current metrics, the company appears to be overvalued, particularly with a Price to Book Value of 0.67 and an EV to Sales ratio of 0.54, which suggest that the market is not pricing in sufficient value relative to its assets and sales. Additionally, the negative EV to EBITDA of -15.22 further underscores the challenges the company faces in generating earnings. In comparison to its peers, Myriad Genetics, Inc. has a significantly lower EV to EBITDA ratio than Owens & Minor, Inc. at 4.7461 and Pacific Biosciences of California, Inc. at -4.2891, indicating that it is struggling more than its competitors in terms of operational efficiency. Furthermore, the company's stock has underperformed relative to the S&P 500, with a year-to-date ret...

View All News